{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2005"],"condition":["","Use for the treatment of advanced/metastatic colorectal cancer, as third/fourth line chemioterapy."],"disease":["","Use For The Treatment Of Advanced/metastatic Colorectal Cancer, As Third/fourth Line Chemioterapy."],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2518268"],"location":["Italy"],"study_start_month":["12"],"keyword":["Brostallicin"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Phase II exploratory study of brostallicin  PNU-166196A  as third/fourth line chemoterapy in adult patients with advanced/metastatic colorectal cancer  CRC .","description":null,"dates":{"creation":"2005-12-15"},"accession":"2518268","cross_references":{"EU Clinical Trials Register":["2005-004200-36"]}}